Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BAG3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | C7orf55-LUC7L2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | JPH1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | AKAIN1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | TSN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | LPAR2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | TSPAN19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ING4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | RGS7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |